Marc‐Alexander Ohlow

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 425 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

A Randomized, Multicenter, Single-Blinded Trial Comparing Paclitaxel-Coated Balloon Angioplasty With Plain Balloon Angioplasty in Drug-Eluting Stent Restenosis

Harald Rittger, Johannes Brachmann, Anil-M. Sinha et al. · Journal of the American College of Cardiology · 2012 · 350 citations

Endovascular Technique, Cardiovascular Disease, Vascular Surgery +7

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 243 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Drug-coated Balloons +6

Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial

Bruno Scheller, Marc‐Alexander Ohlow, Sebastian Ewen et al. · EuroIntervention · 2020 · 139 citations

Cardiac Contractility Modulation Improves Long-Term Survival and Hospitalizations in Heart Failure with Reduced Ejection Fraction

Stefan D. Anker, Martin Borggrefe, Hans Neuser et al. · European Journal of Heart Failure · 2019 · 100 citations